peroxynitrous acid has been researched along with magnolol in 1 studies
Studies (peroxynitrous acid) | Trials (peroxynitrous acid) | Recent Studies (post-2010) (peroxynitrous acid) | Studies (magnolol) | Trials (magnolol) | Recent Studies (post-2010) (magnolol) |
---|---|---|---|---|---|
3,303 | 21 | 1,230 | 560 | 1 | 329 |
Protein | Taxonomy | peroxynitrous acid (IC50) | magnolol (IC50) |
---|---|---|---|
TPA: protein transporter TIM10 | Saccharomyces cerevisiae S288C | 68.3 | |
high affinity choline transporter 1 isoform a | Homo sapiens (human) | 2.2952 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, MS; Lee, CH; Shih, HC | 1 |
1 other study(ies) available for peroxynitrous acid and magnolol
Article | Year |
---|---|
Magnolol attenuates the lung injury in hypertonic saline treatment from mesenteric ischemia reperfusion through diminishing iNOS.
Topics: Animals; Antioxidants; Biphenyl Compounds; Interleukin-6; Lignans; Lung; Male; Mesentery; Mice; Mice, Inbred C3H; Models, Animal; Nitric Oxide Synthase Type II; Peroxides; Peroxynitrous Acid; Pulmonary Edema; Regional Blood Flow; Reperfusion Injury; Saline Solution, Hypertonic; Tumor Necrosis Factor-alpha | 2012 |